NEAR-PERFECT ACCURACY OF A REAL-TIME URINE TENOFOVIR TEST COMPARED TO LAB-BASED ELISA
Therapeutic drug monitoring measures adherence to tenofovir (TFV)-based PrEP more accurately than self-report but has not been available at the point-of-care (POC) until now. We developed an ELISA using a highly-selective antibody to TFV in urine and previously validated it against spectrometry-based methods with high accuracy. We have now developed a lateral flow immunoassay (LFA) using…